BLA Supplements MDUFMA FY 2006
The horizontal bar graph provides FDA final and preliminary “on-time” performance on actions related to BLA Supplements. Performance for FYs 2003, 2004, and 2005 is presented to demonstrate FDA performance prior to the initiation of three on-time goals in FY 2006. All three on-time goals were at 75 percent of actions. Preliminary performance results show FDA exceeding the goal to review and act on BLA manufacturing supplements that require prior approval. The other two goals had no submissions to act on in FY 2006.